ImmuCell outlines capacity expansion plan backed by $2M settlement while focusing on First Defense
Source: SeekingAlpha
2026-05-15 10:41:44 ET
More on ImmuCell
- ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript
- ImmuCell Corporation 2026 Q1 - Results - Earnings Call Presentation
- ImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript
- ImmuCell GAAP EPS of $0.21, revenue of $10.36M
- ImmuCell sees preliminary Q1 revenue of $10.4M
Read the full article on Seeking Alpha
For further details see:
ImmuCell outlines capacity expansion plan backed by $2M settlement while focusing on First Defense
ImmuCell Corporation
NASDAQ: ICCC
ICCC Trading
-6.22% G/L:
$9.50 Last:
4,443 Volume:
$9.77 Open:
ICCC Latest News
May 14, 2026 04:05:00 pm
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
May 07, 2026 04:05:00 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
ICCC Stock Data
$60,757,363
6,377,325
3.65%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Portland
